BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2440311)

  • 1. Angiotensin decreases cyclic GMP accumulation produced by atrial natriuretic factor.
    Smith JB; Lincoln TM
    Am J Physiol; 1987 Jul; 253(1 Pt 1):C147-50. PubMed ID: 2440311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Angiotensin II decreases atrial natriuretic peptide-induced cyclic GMP accumulation in rat glomerular mesangial cells].
    Maeda S
    Nihon Jinzo Gakkai Shi; 1990 Feb; 32(2):183-90. PubMed ID: 2161960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial natriuretic factor alters phospholipid metabolism in mesangial cells.
    Barnett R; Ortiz PA; Blaufox S; Singer S; Nord EP; Ramsammy L
    Am J Physiol; 1990 Jan; 258(1 Pt 1):C37-45. PubMed ID: 1689113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual mechanism of angiotensin II inhibits ANP-induced mesangial cGMP accumulation.
    Haneda M; Kikkawa R; Maeda S; Togawa M; Koya D; Horide N; Kajiwara N; Shigeta Y
    Kidney Int; 1991 Aug; 40(2):188-94. PubMed ID: 1719265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin AT2 receptor mediated inhibition of particulate guanylate cyclase: a link with protein tyrosine phosphatase stimulation?
    Brechler V; Levens NR; De Gasparo M; Bottari SP
    Recept Channels; 1994; 2(2):79-87. PubMed ID: 7525002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of phosphodiesterase isoenzymes and cyclic nucleotide efflux to the regulation of cyclic GMP levels in aortic smooth muscle cells.
    Mercapide J; Santiago E; Alberdi E; Martinez-Irujo JJ
    Biochem Pharmacol; 1999 Nov; 58(10):1675-83. PubMed ID: 10535760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasopressin-mediated inhibition of atrial natriuretic factor-stimulated cGMP accumulation in an established smooth muscle cell line.
    Nambi P; Whitman M; Gessner G; Aiyar N; Crooke ST
    Proc Natl Acad Sci U S A; 1986 Nov; 83(22):8492-5. PubMed ID: 2430290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential antimitogenic effectiveness of atrial natriuretic peptides in primary versus subcultured rat aortic smooth muscle cells: relationship to expression of ANF-C receptors.
    Cahill PA; Hassid A
    J Cell Physiol; 1993 Jan; 154(1):28-38. PubMed ID: 7678266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between atrial natriuretic factor and angiotensin II receptors in the regulation of blood pressure.
    Chabrier PE; Roubert P; Longchamps MO; Plas P; Braquet P
    J Hypertens Suppl; 1988 Dec; 6(4):S290-1. PubMed ID: 2853737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial natriuretic factor and cyclic guanosine 3',5'-monophosphate in vascular smooth muscle.
    Sato M; Abe K; Takeuchi K; Yasujima M; Omata K; Hiwatari M; Kasai Y; Tanno M; Kohzuki M; Kudo K
    Hypertension; 1986 Sep; 8(9):762-71. PubMed ID: 3017853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II decreases cGMP levels in neuronal cultures from rat brain.
    Sumners C; Myers LM
    Am J Physiol; 1991 Jan; 260(1 Pt 1):C79-87. PubMed ID: 1702934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of maitotoxin on atrial natriuretic factor-mediated accumulation of cyclic GMP in PC12 cells.
    Schulick A; Gusovsky F; Yasumoto T; Daly JW
    Life Sci; 1990; 46(10):671-8. PubMed ID: 2156121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ANF and angiotensin II interact via kinases in the proximal straight tubule.
    Garcia NH; Garvin JL
    Am J Physiol; 1995 Apr; 268(4 Pt 2):F730-5. PubMed ID: 7537466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II increases phosphodiesterase 5A expression in vascular smooth muscle cells: a mechanism by which angiotensin II antagonizes cGMP signaling.
    Kim D; Aizawa T; Wei H; Pi X; Rybalkin SD; Berk BC; Yan C
    J Mol Cell Cardiol; 2005 Jan; 38(1):175-84. PubMed ID: 15623434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natriuretic peptides and nitric oxide stimulate cGMP synthesis in different cellular compartments.
    Piggott LA; Hassell KA; Berkova Z; Morris AP; Silberbach M; Rich TC
    J Gen Physiol; 2006 Jul; 128(1):3-14. PubMed ID: 16769793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial natriuretic factor (ANF) inhibits arginine vasopressin-stimulated Ca2+ fluxes and cell contraction in vascular smooth muscle cells.
    Meyer-Lehnert H; Tsai P; Schrier RW
    Klin Wochenschr; 1987; 65 Suppl 8():115-21. PubMed ID: 3037182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. cGMP antagonizes angiotensin-mediated phosphatidylcholine hydrolysis and C kinase activation in mesangial cells.
    Barnett RL; Ruffini L; Ramsammy L; Pasmantier R; Friedlaender MM; Nord EP
    Am J Physiol; 1995 Feb; 268(2 Pt 1):C376-81. PubMed ID: 7864076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic nucleotides in human macrophages: effects of atrial natriuretic factor and nitroprusside on cGMP and cAMP production.
    Houdijk AP; Adolfs MJ; Van Leeuwen PA; Bonta IL; De Jonge HR
    Int J Tissue React; 1991; 13(6):287-93. PubMed ID: 1726323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial natriuretic factor elicits an endothelium-independent relaxation and activates particulate guanylate cyclase in vascular smooth muscle.
    Winquist RJ; Faison EP; Waldman SA; Schwartz K; Murad F; Rapoport RM
    Proc Natl Acad Sci U S A; 1984 Dec; 81(23):7661-4. PubMed ID: 6150486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ANP, angiotensin, vasopressin, and endothelin on ANP receptors in cultured rat vascular smooth muscle cells.
    Schiffrin EL; Turgeon A; Tremblay J; Deslongchamps M
    Am J Physiol; 1991 Jan; 260(1 Pt 2):H58-65. PubMed ID: 1847018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.